{
  "meta": {
    "title": "Genetic_Disorders",
    "url": "https://brainandscalpel.vercel.app/genetic-disorders-6aa4ba2c.html",
    "scrapedAt": "2025-11-29T18:23:25.150Z"
  },
  "questions": [
    {
      "id": 9538,
      "choices": [
        {
          "id": 38119,
          "text": "<p><span style=\"font-size:12.0pt;\">The baby has a 25% chance of clinical disease</span></p>"
        },
        {
          "id": 38120,
          "text": "<p><span style=\"font-size:12.0pt;\">The baby has a 50% chance of being a carrier</span></p>"
        },
        {
          "id": 38121,
          "text": "<p><span style=\"font-size:12.0pt;\">The baby will be a carrier</span></p>"
        },
        {
          "id": 38122,
          "text": "<p><span style=\"font-size:12.0pt;\">The baby has a 50% chance of clinical disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A couple with a 5-year-old son diagnosed with glucose-6-phosphate dehydrogenase (G6PD) deficiency is expecting another child. The mother, currently pregnant, is concerned about her unborn daughter potentially having the same condition, despite both parents being clinically unaffected. Considering the genetic nature of G6PD deficiency, which of the following statements is true regarding the risk to the female fetus?</span></p>",
      "unique_key": "Q5140484",
      "question_audio": null,
      "question_video": null,
      "map_id": 30217,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B. The baby has a 50% chance of being a carrier</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>G6PD deficiency</strong> is an <strong>X-linked recessive</strong> disorder.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Males</strong> (XY) with the defective gene on the X chromosome are <strong>affected</strong>, as they have only one X.</span><ul><li><span style=\"font-size:16px;\"><strong>Females</strong> (XX) need <strong>two defective X chromosomes</strong> to be affected, but if they have only one defective X, they are typically <strong>carriers</strong> (and usually asymptomatic, though some may show mild symptoms due to lyonization/inactivation of the normal X).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">In this scenario:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The <strong>son is affected</strong>, so he must have inherited the defective <strong>X</strong> from his <strong>mother</strong>.</span></li><li><span style=\"font-size:16px;\">Since <strong>father is unaffected</strong>, his X chromosome is <strong>normal</strong>.</span></li><li><span style=\"font-size:16px;\">The <strong>mother must be a carrier</strong> (Xá´ºXáµˆ) â€“ one normal (Xá´º), one defective (Xáµˆ).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Now, for a <strong>female fetus</strong>, she will inherit:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">One <strong>X from father</strong> â†’ always <strong>normal</strong> (Xá´º)</span></li><li><span style=\"font-size:16px;\">One <strong>X from mother</strong> â†’ 50% chance of getting <strong>normal</strong> (Xá´º), 50% chance of <strong>defective</strong> (Xáµˆ)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Thus, the daughter will be:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>50% Xá´ºXá´º</strong> â†’ not a carrier</span></li><li><span style=\"font-size:16px;\"><strong>50% Xá´ºXáµˆ</strong> â†’ carrier</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hence, <strong>50% chance of being a carrier</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Final Answer: B. The baby has a 50% chance of being a carrier</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><img class=\"image_resized\" style=\"aspect-ratio:350/178;width:86.83%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture5_PzSv4Iw.jpg\" alt=\"\" width=\"350\" height=\"178\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">G6PD deficiency is the most common enzyme deficiency leading to hemolytic anemia. It affects the pentose phosphate pathway, reducing the production of NADPH, which is essential for maintaining reduced glutathione that protects cells from oxidative damage. This condition predominantly affects males, while female carriers are usually asymptomatic.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref</strong>: Harper 30/e:&nbsp; p 693-694.</span></p>",
      "correct_choice_id": 38120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9540,
      "choices": [
        {
          "id": 38127,
          "text": "<p><span style=\"font-size:12.0pt;\">Result A</span></p>"
        },
        {
          "id": 38128,
          "text": "<p><span style=\"font-size:12.0pt;\">Result B</span></p>"
        },
        {
          "id": 38129,
          "text": "<p><span style=\"font-size:12.0pt;\">Result C</span></p>"
        },
        {
          "id": 38130,
          "text": "<p><span style=\"font-size:12.0pt;\">Result D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-day-old infant exhibits difficulty feeding, cyanosis post-feeding, general hypotonia, and a detectable heart murmur. On examination, the infant has a flat occiput, epicanthic folds, and a single palmar crease. There is a noted family history of Down syndrome. Given these clinical findings, which karyotype result from the chromosome analysis provided would you expect to find in this case?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img class=\"image_resized\" style=\"aspect-ratio:2719/2408;width:81.37%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/patho1.png\" width=\"2719\" height=\"2408\"></p>",
      "unique_key": "Q5745473",
      "question_audio": null,
      "question_video": null,
      "map_id": 30218,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Result C</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical clues:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">3-day-old with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Feeding difficulty, cyanosis, hypotonia.</span></li><li><span style=\"font-size:12.0pt;\">Heart murmur.</span></li><li><span style=\"font-size:12.0pt;\">Flat occiput, epicanthic folds, single palmar crease.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Family history of Down syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All signs are classic for Trisomy 21 (Down syndrome)&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As seen in the karyotype of image C&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">47 chromosomes total, Three copies of chromosome 21</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;<strong><u>Explanation</u></strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Result</strong>: Would likely represent a normal karyotype, which would not be consistent with the clinical presentation of Down syndrome.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Result</strong>: Could indicate another chromosomal abnormality that does not align with Down syndrome's typical presentation, possibly a translocation or deletion.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Result</strong>: Could indicate another chromosomal abnormality that does not align with Down syndrome's typical presentation, possibly a translocation or deletion&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Down syndrome is characterized by an extra copy of chromosome 21, which is a trisomy.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan&nbsp; 9/e: p 635</span></p>",
      "correct_choice_id": 38129,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9409,
      "choices": [
        {
          "id": 37603,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiation of dystrophin transcription will be defective.</span></p>"
        },
        {
          "id": 37604,
          "text": "<p><span style=\"font-size:12.0pt;\">Termination of dystrophin transcription will be defective.</span></p>"
        },
        {
          "id": 37605,
          "text": "<p><span style=\"font-size:12.0pt;\">Capping and splicing of dystrophin messenger RNA will be defective.</span></p>"
        },
        {
          "id": 37606,
          "text": "<p><span style=\"font-size:12.0pt;\">Tailing of dystrophin messenger RNA will be defective.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In a pediatric clinic in New Delhi, a 5-year-old child is diagnosed with Duchenne muscular dystrophy, a severe muscle-wasting disease. Genetic testing reveals a mutation in the promoter region of the gene responsible for producing dystrophin, a crucial muscle protein. Considering the role of promoter regions in gene expression, which of the following is the most likely consequence of this mutation on dystrophin production?</span></p>",
      "unique_key": "Q1991815",
      "question_audio": null,
      "question_video": null,
      "map_id": 30216,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Initiation of dystrophin transcription will be defective&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;&nbsp;</strong></span></p><p style=\"text-align:justify;\"><span style=\"font-size:11pt;\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Mutations </strong>in the <strong>promoter region prevents </strong>the <strong>formation of RNA polymerase II transcription complex </strong>ðŸ¡ª<strong>decrease </strong>in the <strong>initiation of mRNA synthesis</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A <strong>deficiency of dystrophin mRNA </strong>will lead to <strong>deficiency of the dystrophin protein</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\"><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> <strong>Termination defects </strong>are related to <strong>sequences </strong>and <strong>factors at the end of the gene</strong>, not the promoter region.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> <strong>Capping </strong>and <strong>splicing are post-transcriptional modifications </strong>and generally not directly affected by promoter mutations.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> <strong>Polyadenylation </strong>(tailing) is another <strong>post-transcriptional event </strong>typically not influenced by mutations in the promoter region.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A <strong>mutation </strong>in the <strong>promoter region </strong>of the <strong>dystrophin gene </strong>with <strong>Duchenne muscular dystrophy</strong>, is likely to <strong>impair the initiation </strong>of <strong>dystrophin transcription</strong>. This is because the promoter region is essential for the start of transcription, and its mutation disrupts the normal production of dystrophin, a key protein for muscle function.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Harper 30/e: p 655</strong></span></p>",
      "correct_choice_id": 37603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9557,
      "choices": [
        {
          "id": 38195,
          "text": "<p><span style=\"font-size:12.0pt;\">Single nucleotides change in a codon</span></p>"
        },
        {
          "id": 38196,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoantibodies against RBC membrane</span></p>"
        },
        {
          "id": 38197,
          "text": "<p><span style=\"font-size:12.0pt;\">Genomic imprinting</span></p>"
        },
        {
          "id": 38198,
          "text": "<p><span style=\"font-size:12.0pt;\">Triple nucleotide repeats</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 6-year-old boy is brought to the clinic with severe abdominal pain, recurrent infections, and a history of chronic hemolytic anemia. On examination, he has a non-healing ulcer on his right leg, and a peripheral blood smear shows abnormally shaped red blood cells. What is the basic genetic defect associated with this disorder?</span></p>",
      "unique_key": "Q1165940",
      "question_audio": null,
      "question_video": null,
      "map_id": 30220,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Single nucleotide change in a codon.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">This is a case of <strong>sickle cell anemia </strong>causing <strong>production of abnormal Hemoglobin HbS</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>HbS arises </strong>from a <strong>point mutation </strong>which <strong>substitutes thymine </strong>for <strong>adenine in the 6<sup>th</sup> codon </strong>of the <strong>beta-globin chain gene</strong>, GTG at the place of GAG ðŸ¡ª causes coding of valine [GTG] instead of glutamate [GAG] in position 6 of the Hb beta chain.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Resulting Hb:</strong> forms polymers under deoxy conditions, exhibits changes in solubility and molecular stability ðŸ¡ª these properties are responsible for the profound clinical expressions of the sickling syndromes.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Autoantibodies against RBC membrane: </strong>are seen in <strong>AIHA </strong>(autoimmune haemolytic anemia).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Genomic imprinting:</strong> in this, <strong>expression of some genes </strong>depends on whether or not they are inherited maternally or paternally e.g. Angelman syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Triple nucleotide repeats:</strong> These<strong> </strong>are associated with diseases such as <strong>CGG repeat sequence </strong>- <strong>fragile X syndrome</strong>, <strong>CAG repeats </strong>- <strong>Huntingtonâ€™s chorea</strong>, CTG -myotonic dystrophy and CAG in spinobulbar muscular atrophy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective</u></strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Sickle cell anemia </strong>is caused by a <strong>single nucleotide substitution </strong>in the <strong>Î²-globin gene</strong>, which leads to the <strong>replacement of glutamic acid </strong>with <strong>valine </strong>at the <strong>sixth position of the Î²-globin chain</strong>. This single amino acid change results in the production of hemoglobin S (HbS), which polymerizes under low-oxygen conditions, causing the red blood cells to take on a sickle shape and leading to hemolytic anemia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Harper 30/e:&nbsp; p 58, 417.</strong></span></p>",
      "correct_choice_id": 38195,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9351,
      "choices": [
        {
          "id": 37371,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Turner syndrome</span></span></span></p>"
        },
        {
          "id": 37372,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Edwards syndrome </span></span></span></p>"
        },
        {
          "id": 37373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fragile X syndrome&nbsp;&nbsp; </span></span></span></p>"
        },
        {
          "id": 37374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Klinefelter syndrome&nbsp; </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a routine evaluation, a 4-year-old boy with developmental delays is noted to have distinct facial features, including a long face and large ears, along with macroorchidism. The boy&#39;s family history reveals a pattern of intellectual disability predominantly affecting male relatives. Based on the clinical presentation and family history, the physician suspects a genetic condition characterized by a trinucleotide repeat expansion. Which of the following diagnoses is most consistent with these findings?</span></span></span></p>",
      "unique_key": "Q2461230",
      "question_audio": null,
      "question_video": null,
      "map_id": 30208,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Fragile X syndrome </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fragile X syndrome</strong> has an <strong>abnormal genetic makeup</strong> - <strong>increase in number</strong> of <strong>trinucleotide</strong> repeat sequences (microsatellite instability).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F includes enlarged testes (most specific), mental retardation. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Larger the number of repeats, higher is the probability of retardation.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affected sisters have mild MR than their brothers.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Turner syndrome </strong>is a <strong>chromosomal disorder </strong>involving a <strong>missing or partially missing X chromosome</strong>, affecting only females, and is characterized by short stature and ovarian dysfunction, not intellectual disability.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Edwards syndrome,</strong> or <strong>trisomy 18</strong>, is a <strong>chromosomal condition </strong>associated with a <strong>wide spectrum</strong> of severe clinical manifestations, including profound developmental delays and structural anomalies; it is not a trinucleotide repeat disorder.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Klinefelter syndrome</strong> is characterized by the <strong>presence of an extra X chromosome in males</strong> (47, XXY) and is associated with <strong>hypogonadism </strong>and <strong>reduced fertility,</strong> but not typically with the facial features or intellectual disability pattern seen in Fragile X syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture4.jpg\" style=\"height:234px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p378, DM Vasudevan 9/e: p 578.</span></strong></span></span></p>",
      "correct_choice_id": 37373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9567,
      "choices": [
        {
          "id": 38235,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">47, XX, +21</span></span></p>"
        },
        {
          "id": 38236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">46, XX</span></span></span></p>"
        },
        {
          "id": 38237,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">47, XX, +18</span></span></p>"
        },
        {
          "id": 38238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">47, XX, +21/46, XX</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A female patient presents with features suggestive of Down syndrome. However, not all cells appear to have the typical trisomy 21 on karyotype analysis. Some of her cells have a normal karyotype. Which of the following is the correct cytogenetic notation for this presentation of Down syndrome mosaicism?<strong> </strong></span></span></span></p>",
      "unique_key": "Q4215692",
      "question_audio": null,
      "question_video": null,
      "map_id": 30223,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. 47, XX, +21/46, XX</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The correct <strong>notation for a female</strong> with <strong>Down syndrome mosaicism</strong> is <strong>&quot;47, XX, +21/46,XX,&quot;</strong> which indicates that there are <strong>two cell lines;</strong> <strong>one with trisomy 21</strong> (47 chromosomes including an extra chromosome 21) and one with the <strong>normal chromosomal count</strong> (46 chromosomes).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>A:</strong> <strong>47, XX, +21</strong>: This <strong>notation</strong> indicates a <strong>non-mosaic form of Down syndrome </strong>where all cells have an extra chromosome 21.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong><span style=\"font-size:12.0pt\"> <strong>46, XX: </strong>This represents a <strong>normal female karyotype </strong>with no extra chromosomes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>C:</strong> <strong>47, XX, +18: </strong>This would indicate <strong>trisomy 18, </strong>not Down syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Mosaicism</strong> occurs when a <strong>chromosomal anomaly </strong>affects one of several <strong>precursor cells </strong>of an <strong>embryo or tissue</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>two or more karyotypes</strong> which characterize the <strong>mosaic cells</strong> are separated by a <strong>slash in cytogenetic notation. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The nomenclature <strong>47, XX, +21</strong> denotes a <strong>cell line typical of a female with trisomy 21</strong> (Down syndrome)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">46, XX</span></strong><span style=\"font-size:12.0pt\"> is the karyotype <strong>expected for a normal female</strong> and <strong>XY sex chromosomes</strong> refer to a <strong>male</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">About <strong>95% of patients</strong> with <strong>Down syndrome</strong> have <strong>trisomy 21, </strong>while 3% to 4% have translocations and 1% mosaicism.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e</span></span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>p 324, 635.</strong></span></span></p>",
      "correct_choice_id": 38238,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9533,
      "choices": [
        {
          "id": 38099,
          "text": "<p><span style=\"font-size:12.0pt;\">She has a 25% chance of having Tay-Sachs disease.</span></p>"
        },
        {
          "id": 38100,
          "text": "<p><span style=\"font-size:12.0pt;\">She has a 50% chance of having Tay-Sachs disease.</span></p>"
        },
        {
          "id": 38101,
          "text": "<p><span style=\"font-size:12.0pt;\">She is a carrier for Tay-Sachs disease.</span></p>"
        },
        {
          "id": 38102,
          "text": "<p><span style=\"font-size:12.0pt;\">She is homozygous normal.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A genetic counsellor is reviewing the case of an Ashkenazi Jewish family with a 7-month-old son diagnosed with Tay-Sachs disease, an autosomal recessive disorder. If son is a diagnosed case of Tay-Sachs disease. The family's pedigree and Southern blot analysis, with RFLP linked to the Tay-Sachs gene, have been presented to determine the genetic status of their daughter. What does the Southern blot analysis indicate regarding the daughter's genetic status concerning Tay-Sachs disease?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/1230.png\" width=\"424\" height=\"257\"></span></p>",
      "unique_key": "Q9883899",
      "question_audio": null,
      "question_video": null,
      "map_id": 30214,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. She is homozygous normal.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p><span style=\"font-size:12.0pt;\">From the pedigree and Southern blot:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The son has Tay-Sachs disease (as mentioned in question), which is autosomal recessive, meaning he has two mutant alleles.</span></li><li><span style=\"font-size:12.0pt;\">The father and mother must both be carriers (heterozygous), since their son has the disease.</span></li><li><span style=\"font-size:12.0pt;\">The Southern blot shows RFLP patterns linked to the Tay-Sachs gene for all family members.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Looking at the band patterns:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The son (affected) shows only the 3 kb bands, which must represent the disease allele.</span></li><li><span style=\"font-size:12.0pt;\">The father shows both 3 kb and 4 kb bands, indicating he's a carrier.</span></li><li><span style=\"font-size:12.0pt;\">The mother shows both 3 kb and 4 kb bands, indicating she's a carrier.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The daughter shows&nbsp;only 4 kb bands. so she must be homozygous normal for the&nbsp; gene.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture3_0u6xcgZ.jpg\" alt=\"\" width=\"800\" height=\"476\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 25% chance of having Tay-Sachs disease</strong>: This is a statistical likelihood for offspring when both parents are carriers, but it speaks more to probability than to actual genetic findings from the analysis of Southern blot.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 50% chance of having Tay-Sachs disease</strong>: This might be considered if one parent is affected and the other is a carrier, but it speaks more to probability than to actual genetic findings from the analysis of Southern blot.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carrier for Tay-Sachs disease</strong>: This would mean the child inherited one normal and one mutated gene. The absence of the mutated gene in&nbsp; Southern blot analysis&nbsp; negates this option.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Southern blot analysis is a method used to detect specific DNA sequences, making it valuable for diagnosing genetic conditions. In the context of Tay-Sachs disease, which is an autosomal recessive disorder, a person must inherit two defective copies of the gene to manifest the disease.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan&nbsp; 9/e: p 635</span></p>",
      "correct_choice_id": 38102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9551,
      "choices": [
        {
          "id": 38171,
          "text": "<p><span style=\"font-size:12.0pt;\">Result A</span></p>"
        },
        {
          "id": 38172,
          "text": "<p><span style=\"font-size:12.0pt;\">Result B</span></p>"
        },
        {
          "id": 38173,
          "text": "<p><span style=\"font-size:12.0pt;\">Result C</span></p>"
        },
        {
          "id": 38174,
          "text": "<p><span style=\"font-size:12.0pt;\">Result D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3 days old infant feeds poorly, chokes and turns blue after breastfeeding. O/E â€“ the infant is floppy with a heart murmur and has flat occiput, folds over the inner corners of the eyes, single palmar crease etc. Family history of Down syndrome present. From the below chromosome analysis, which of the results is most likely in this case?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:791/700;width:79.15%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/100001.jpg\" width=\"791\" height=\"700\"></span></p>",
      "unique_key": "Q4183761",
      "question_audio": null,
      "question_video": null,
      "map_id": 30219,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Result C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical scenario described â€” poor feeding, cyanosis, hypotonia (\"floppy\"), heart murmur, flat occiput, epicanthal folds, single palmar crease, and family history of Down syndrome â€” strongly suggests Trisomy 21 (Down syndrome).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What are we looking for?</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">In the karyotype, Down syndrome = Trisomy 21, so:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">47 chromosomes total.</span></li><li><span style=\"font-size:12.0pt;\">Three copies of chromosome 21</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Result</strong>: Would likely represent a normal karyotype, which would not be consistent with the clinical presentation of Down syndrome.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Result</strong>: Could indicate another chromosomal abnormality that does not align with Down syndrome's typical presentation, possibly a translocation or deletion.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Result</strong>: Could indicate another chromosomal abnormality that does not align with Down syndrome's typical presentation, possibly a translocation or deletion&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>&nbsp;</u></strong></span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Down syndrome is characterized by an extra copy of chromosome 21, which is a trisomy.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan&nbsp; 9/e: p 635</span></p>",
      "correct_choice_id": 38173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9573,
      "choices": [
        {
          "id": 38259,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">X-linked recessive</span></span></span></p>"
        },
        {
          "id": 38260,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Autosomal dominant</span></span></span></p>"
        },
        {
          "id": 38261,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Autosomal recessive</span></span></span></p>"
        },
        {
          "id": 38262,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">X-linked dominant</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a family affected by Charcot-Marie-Tooth disease, restriction analysis of the genomic region surrounding the CMT gene on chromosome 17 produces one large abnormal fragment and one smaller fragment common to unaffected controls. Based on this information, what is the most likely pattern of inheritance for Charcot-Marie-Tooth disease in this family?</span></span></span></p>",
      "unique_key": "Q2574344",
      "question_audio": null,
      "question_video": null,
      "map_id": 30224,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B.</span></strong><span style=\"font-size:12.0pt\"> <strong>Autosomal dominant</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>DNA duplication </strong>is one form of <strong>atypical inheritance.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>large fragment </strong>could <strong>derive </strong>from a <strong>mutation ablating one flanking restriction site </strong>or from extra DNA inserted between the restriction sites. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">There are <strong>two DNA fragment sizes </strong>in the <strong>affected individual </strong>but one in controls suggests <strong>alteration of only one of the two homologous CMT regions </strong>on <strong>chromosome 17</strong>. The production of disease by alteration of one homologous locus (one abnormal allele) causes autosomal dominant inheritance. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This <strong>form of CMT </strong>is caused by a <strong>duplication of the <em>PMP22 </em>gene</strong>, a gene encoding a peripheral myelin protein and an extra copy of <em>PMP22 </em>increases protein abundance and interferes with nerve conduction.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>A. X-linked recessive:</strong> This is <strong>less likely </strong>since <strong>Charcot-Marie-Tooth disease</strong>, especially types associated with chromosome 17 mutations, typically does not follow an X-linked pattern of inheritance.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>C. Autosomal recessive:</strong> In autosomal recessive conditions, <strong>two mutated alleles </strong>are necessary for the <strong>manifestation of the disease</strong>, which does not align with the finding of one normal and one abnormal fragment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>D. X-linked dominant:</strong> This is also <strong>unlikely </strong>for <strong>Charcot-Marie-Tooth disease</strong>, given its known genetic basis and typical autosomal dominant inheritance pattern.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Charcot-Marie-Tooth disease </strong>is commonly <strong>inherited </strong>in an <strong>autosomal dominant manner</strong>, particularly for <strong>mutations </strong>found on <strong>chromosome 17</strong>, which often <strong>involve the PMP22 gene</strong>. The presence of one abnormal fragment in the <strong>restriction analysis </strong>suggests a <strong>mutation</strong> or <strong>alteration in one allele of the gene</strong>, while the <strong>other allele appears normal</strong> (as indicated by the smaller fragment seen in controls). This pattern is consistent with autosomal dominant inheritance, where a single mutated allele can cause the disease phenotype.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 635</span></span></strong></p>",
      "correct_choice_id": 38260,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9619,
      "choices": [
        {
          "id": 38443,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Germ-line gene therapy to replace one <em>ADA </em>gene copy</span></span></span></p>"
        },
        {
          "id": 38444,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Germ-line gene therapy to replace both <em>ADA </em>gene copies</span></span></span></p>"
        },
        {
          "id": 38445,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Somatic cell gene therapy to replace both <em>ADA </em>gene copy in circulating lymphocytes</span></span></span></p>"
        },
        {
          "id": 38446,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Somatic cell gene therapy to replace one <em>ADA </em>gene copy in bone marrow lymphoblasts</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-month-old boy with chronic yeast diaper rash and multiple episodes of pneumonia, including blood cultures positive for Group A streptococcus, is suspected to have a compromised immune system. Given the rarity of Group A strep infections in infants and the indications of defective B-cells and T-cells, his physician diagnoses him with severe combined immune deficiency (SCID). Which treatment could permanently cure the patient?</span></span></span></p>",
      "unique_key": "Q2567284",
      "question_audio": null,
      "question_video": null,
      "map_id": 30210,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Somatic cell gene therapy to replace one <em>ADA </em>gene copy in bone marrow lymphoblasts.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gene therapy </strong>refers to a <strong>group of techniques </strong>by which <strong>gene structure </strong>or expression is <strong>altered to ameliorate a disease</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Germ-line therapy&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">involving <strong>alterations of genes </strong>in <strong>primordial germ cells </strong>is not being explored in humans. But performed in animals that alters the characteristics of offspring rather than the treated individuals.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Somatic cell gene therapy&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>targeted to an affected tissue </strong>or <strong>group of tissues </strong>in the individual and is most&nbsp;<strong>effective </strong>if <strong>stem cells </strong>such as <strong>bone marrow can be treated</strong>. It helps in <strong>replacing damaged tissue </strong>without the <strong>rejection problems of transplantation. </strong>For autosomal recessive disorders, only one of the two defective alleles must be replaced or supplemented.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Somatic gene therapy </strong>to <strong>correct stem cells </strong>such as <strong>bone marrow </strong>would give a continuous source of ADA enzyme and curative therapy; germ-line therapy would target his spermatogonia and thus future offspring.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B &amp; Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> For <strong>autosomal recessive disorders</strong>, only <strong>one of the two defective alleles </strong>should be <strong>replaced </strong>or supplemented to allow normal enzyme function. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>permanent cure for SCID</strong>, especially for <strong>ADA-SCID </strong>(adenosine deaminase deficiency), typically involves <strong>gene therapy </strong>that <strong>targets the bone marrow cells</strong>, as these are the <strong>progenitors of the immune system</strong>. Somatic cell gene therapy targeting the bone marrow can lead to the development of a functional immune system.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 31 e: p 1086.</span></strong></span></span></p>",
      "correct_choice_id": 38446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9661,
      "choices": [
        {
          "id": 38611,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SCID</span></span></span></p>"
        },
        {
          "id": 38612,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cancer</span></span></span></p>"
        },
        {
          "id": 38613,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haemophilia</span></span></span></p>"
        },
        {
          "id": 38614,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystic fibrosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a medical conference on the advancements in genetic treatments, a speaker highlights the milestone of the first successful gene therapy targeting a somatic enzyme deficiency. This groundbreaking therapy was primarily applied to treat which condition?<strong> </strong></span></span></span></p>",
      "unique_key": "Q7401771",
      "question_audio": null,
      "question_video": null,
      "map_id": 30213,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) SCID</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>first successful gene therapy</strong> was applied to <strong>treat Severe Combined Immunodeficiency</strong> (SCID), specifically a form known as <strong>ADA-SCID</strong> (adenosine deaminase deficiency SCID). This therapy involved <strong>inserting a functional copy of the ADA gene</strong> into the <strong>patient&#39;s own blood cells, </strong>correcting the <strong>enzyme deficiency</strong> and <strong>restoring immune function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Cancer:</strong> While <strong>gene therapy</strong> is being <strong>explored for cancer treatment,</strong> it was not the first condition successfully treated with gene therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Haemophilia:</strong> <strong>Gene therapy</strong> has shown <strong>promise in treating haemophilia</strong>, but it was not the first disease targeted by successful gene therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Cystic fibrosis</strong>: <strong>Gene therapy trials</strong> have been <strong>conducted for cystic fibrosis,</strong> but the first successful application of gene therapy was for SCID.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dr French Anderson did the first gene therapy to treat SCID.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gene Therapy&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the intracellular delivery of genes to produce a therapeutic effect by correcting an existing abnormality. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is divided into:</span></span></span></li>\r\n</ul>\r\n\r\n<ol style=\"margin-left:40px\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Somatic cell gene therapy&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- Gene is introduced into somatic cells.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Germ cell gene therapy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (Transgenic animal).</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: p 648.</span></strong></span></span></p>",
      "correct_choice_id": 38611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7691,
      "choices": [
        {
          "id": 30732,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100 %</span></span></span></p>"
        },
        {
          "id": 30733,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">75%</span></span></p>"
        },
        {
          "id": 30734,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">50%</span></span></span></p>"
        },
        {
          "id": 30735,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">25%</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newly married couple visits a genetic counseling clinic as they are expecting their first child. Their medical history reveals that both the husband and wife carry the sickle-cell trait. The couple is aware of the genetic implications and is seeking advice on the likelihood of their child being affected by sickle-cell anemia. Given that both parents are carriers of the sickle-cell trait, what is the risk that their offspring will inherit sickle-cell anemia?</span></span></span></p>",
      "unique_key": "Q5357701",
      "question_audio": null,
      "question_video": null,
      "map_id": 30209,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">25%&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sickle cell anemia </strong>is a disease with <strong>autosomal recessive inheritance</strong>, due to <strong>mutation </strong>in the<strong> beta-globin gene. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When<strong> both parents</strong> are having <strong>sickle-cell trait</strong> (carriers of the abnormal gene) the <strong>risk of offspring getting affected</strong> would be<strong> 25% (sickle-cell anemia with two abnormal genes).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The chances of having a<strong> child as a carrier</strong> would be <strong>50% (sickle &ndash;cell trait with one abnormal gene) </strong>and a <strong>normal child</strong> is <strong>25% (no abnormal gene).</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100% and Option B: 75%:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> If the disease is with<strong> Mendelian inheritance, </strong>the<strong> risk </strong>to the <strong>offspring </strong>would be <strong>more than 50%. </strong>E.g: if<strong> both parents have (homozygous state) sickle cell anemia</strong>, then the<strong> risk</strong> would be <strong>100%.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">50%:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> For diseases with <strong>autosomal dominant inheritance </strong>like<strong> Huntington&#39;s chorea </strong>the<strong> risk of child </strong>getting affected is <strong>50% </strong>if <strong>one </strong>parent is <strong>affected</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inheritance Pattern &ndash;</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture16.jpg\" style=\"height:284px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: p 608-611.</span></strong></span></span></p>",
      "correct_choice_id": 30735,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17156,
      "choices": [
        {
          "id": 68584,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inclusion cell disease</span></span></span></p>"
        },
        {
          "id": 68585,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zellweger syndrome</span></span></span></p>"
        },
        {
          "id": 68586,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Infantile Refsum&#39;s Disease</span></span></span></p>"
        },
        {
          "id": 68587,
          "text": "<p style=\"margin-right:28px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Refsum&#39;s Disease</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">During a pediatric residency rotation, residents are presented with a case of a 1-year-old girl who exhibits severe psychomotor retardation, skeletal anomalies, and coarse facial features. Extensive lysosomal enzyme testing reveals low activities of mannosidase, fructosidase, glucuronidase, and galactosidase in leukocytes and fibroblasts, while high levels of these enzymes are observed in plasma. Based on these clinical and laboratory findings, the residents are asked to determine the most likely diagnosis. What condition does this child most likely have?</span></span></span></p>",
      "unique_key": "Q3435572",
      "question_audio": null,
      "question_video": null,
      "map_id": 30206,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Inclusion cell disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Inclusion cell (I-cell) disease</strong> is a condition in which <strong>lysosomes</strong> <strong>lack</strong> in <strong>enzymes</strong> <strong>but are seen in blood.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Mannose-6-phosphate</strong> is the marker enzyme to target the <strong>nascent enzymes to lysosomes. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In<strong> I CELL DISEASE</strong> - the <strong>carbohydrate units </strong>are<strong> not </strong>added to the enzyme &rarr;<strong>Mannose-6-phosphate deficient</strong> enzymes <strong>cannot </strong>reach their<strong> destination (protein targeting defect).</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. &nbsp;Zellweger syndrome</span></strong><span style=\"font-size:12.0pt\"> is due to<strong> defective oxidation</strong> of <strong>very long chain fatty acids</strong> (VLCFA).<strong> Peroxisomes </strong>are <strong>empty</strong> or <strong>peroxisomal enzymes </strong>are <strong>not</strong> transported correctly into peroxisomes &rarr; leads to <strong>insufficient oxidation </strong>of <strong>VLCFA </strong>&rarr; <strong>accumulation</strong> of <strong>VLCFA in CNS</strong> &rarr; <strong>neurological impairment</strong> and<strong> death </strong>in childhood.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. It is also a peroxisomal</span></strong><span style=\"font-size:12.0pt\"> disorder&rarr; <strong>phytanic acid </strong>accumulation along with <strong>VLCFA </strong>&amp; Children <strong>do not </strong>survive<strong> long.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Due to lack of alpha-hydroxylase</span></strong><span style=\"font-size:12.0pt\"> &rarr; <strong>alpha oxidation does not </strong>occur &rarr;<strong> phytanic acid </strong>accumulates in the tissues &rarr;&nbsp;<strong>C/F: </strong>s<strong>evere neurological symptoms, polyneuropathy, retinitis pigmentosa, nerve deafness and cerebellar ataxia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Inclusion cell (I-cell) disease</strong>, or <strong>mucolipidosis type II,</strong> is a l<strong>ysosomal storage disorder </strong>characterized by <strong>defective trafficking </strong>of l<strong>ysosomal enzymes</strong>. Normally, these <strong>enzymes </strong>are<strong> targeted </strong>to the <strong>lysosomes</strong> within cells; however, in <strong>I-cell disease</strong>, they are mistakenly s<strong>ecreted outside the cell</strong>, leading to <strong>low enzyme activity</strong> in cells (like <strong>leukocytes and fibroblasts)</strong> and <strong>high levels </strong>in the <strong>plasma</strong>. The <strong>clinical features</strong> described, including <strong>psychomotor retardation, skeletal anomalies, and coarse facial features</strong>, <strong>align</strong> with the presentation of<strong> I-cell disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 30/e p586.</span></strong></span></span></p>",
      "correct_choice_id": 68584,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18006,
      "choices": [
        {
          "id": 71982,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ionizing radiation</span></span></span></p>"
        },
        {
          "id": 71983,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mutagenic chemicals</span></span></span></p>"
        },
        {
          "id": 71984,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oncogenic viruses</span></span></span></p>"
        },
        {
          "id": 71985,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following factor is recognized as capable of converting a normal cell into a cancer cell?</span></span></span></p>",
      "unique_key": "Q8647940",
      "question_audio": null,
      "question_video": null,
      "map_id": 30221,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ionizing radiation:</span></strong><span style=\"font-size:12.0pt\"> It can cause <strong>direct DNA damage</strong>, leading to <strong>mutations </strong>that may result in <strong>cancer </strong>if <strong>not </strong>properly <strong>repaired</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Mutagenic chemicals:</span></strong><span style=\"font-size:12.0pt\"> These <strong>substances </strong>can <strong>interact </strong>with <strong>DNA </strong>to cause <strong>mutations</strong>, some of which might confer a <strong>growth advantage to cells</strong>, leading to <strong>cancer</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Oncogenic viruses:</span></strong><span style=\"font-size:12.0pt\"> Certain <strong>viruses </strong>have the ability to <strong>integrate </strong>their <strong>genetic material </strong>into the <strong>host cell&#39;s genome</strong>, potentially <strong>activating oncogenes </strong>or <strong>inactivating </strong>tumor <strong>suppressor genes</strong>, thereby <strong>inducing tumorigenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Substances which <strong>increase the rate of mutation </strong>in turn <strong>enhance </strong>the rate of <strong>incidence of cancer </strong>&rarr; hence, <strong>all carcinogens are mutagens</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">E.g</span></strong><span style=\"font-size:12.0pt\">: <strong>Radiations: X-rays, gamma rays, ultraviolet rays.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chemicals:</span></strong><span style=\"font-size:12.0pt\"> (a) occupation (aniline, asbestos), (b) diet (aflatoxins), (c) lifestyle (smoking).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Oncogenic viruses</span></strong><span style=\"font-size:12.0pt\">: <strong>Epstein-Barr virus</strong>, <strong>Human papillomavirus</strong>, <strong>Hepatitis B virus, Hepatitis C virus</strong>, <strong>Human immunodeficiency virus </strong>etc</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">: DM Vasudevan 9/e: p 711.</span></strong></span></span></p>",
      "correct_choice_id": 71985,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17149,
      "choices": [
        {
          "id": 68556,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Marfan syndrome</span></span></span></p>"
        },
        {
          "id": 68557,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Menke&rsquo;s Disease</span></span></span></p>"
        },
        {
          "id": 68558,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehlers-Danlos Syndrome (EDS)</span></span></span></p>"
        },
        {
          "id": 68559,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alport Syndrome</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a cardiology clinic, a 25-year-old male presents with intermittent chest pain lasting about 10 minutes, a recent onset of visual difficulties, and notable physical characteristics. On examination, the patient is observed to be tall and thin with long extremities. A slit lamp examination reveals an upward dislocation of the lens in the right eye, and an echocardiogram indicates aortic regurgitation. Based on these findings, the cardiologist is considering a specific diagnosis. What is the most likely diagnosis for this patient?<strong> </strong></span></span></span></p>",
      "unique_key": "Q6180344",
      "question_audio": null,
      "question_video": null,
      "map_id": 30227,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Marfan syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Marfan syndrome</strong> is inherited as an <strong>autosomal dominant trait. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Due to a <strong>defect in the gene,</strong> coding for a connective tissue protein,<strong> fibrillin-1.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Arachnodactyly</strong><strong> </strong>(long digits), <strong>ectopia lentis</strong> (dislocation of lens), <strong>hyperextension of joints,</strong> <strong>aortic aneurysm </strong>are classical manifestations of the syndrome.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Menke&rsquo;s Disease&nbsp;</span></strong><span style=\"font-size:12.0pt\">is due to <strong>deficiency of copper</strong>&nbsp; <span style=\"font-family:Wingdings\">&rarr;</span><strong> defective</strong> function of<strong> lysyl oxidase</strong> &rarr; reduced <strong>cross linkage</strong> of collagen.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ehlers-Danlos Syndrome (EDS)&nbsp;</span></strong><span style=\"font-size:12.0pt\">is due to <strong>defective Type III collagen </strong>formation due to <strong>defect in lysyl oxidase </strong>or <strong>lysyl</strong> <strong>hydroxylase</strong> <span style=\"font-family:Wingdings\">&rarr;</span> resulting in <strong>weakening of collagen, loose skin, hypermobile and lax joints. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Alport Syndrome&nbsp;</span></strong><span style=\"font-size:12.0pt\">is due to<strong> defective Type IV collagen</strong> &rarr;&nbsp;<strong>abnormalities </strong>in <strong>glomerular basement membrane</strong>&nbsp;<span style=\"font-family:Wingdings\">&rarr;</span>&nbsp;<strong> hematuria;</strong> progress to <strong>kidney failure</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Marfan syndrome,</strong> a genetic connective tissue disorder; Key features are<strong> tall stature</strong> with <strong>long extremities, lens dislocation</strong> (ectopia lentis), and cardiovascular<strong> </strong>abnormalities such as <strong>aortic regurgitation.</strong> <strong>Marfan syndrome</strong> is known to affect the<strong> skeletal system, eyes,</strong> and <strong>cardiovascular system.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">: DM Vasudevan 9/e: p 723.</span></strong></span></span></p>",
      "correct_choice_id": 68556,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17158,
      "choices": [
        {
          "id": 68592,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ras proto-oncogene</span></span></span></p>"
        },
        {
          "id": 68593,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">erbB proto-oncogene</span></span></span></p>"
        },
        {
          "id": 68594,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">p53 gene</span></span></span></p>"
        },
        {
          "id": 68595,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RB1 gene</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An oncology resident is reviewing the genetic underpinnings of various cancers and comes across a case of retinoblastoma, a rare pediatric eye cancer. The resident recalls that a specific genetic mutation is known to play a key role in the development of this cancer. Which gene, when mutated, is most commonly associated with the development of retinoblastoma?</span></span></span></p>",
      "unique_key": "Q7691821",
      "question_audio": null,
      "question_video": null,
      "map_id": 30207,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) RB1 gene</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>RB protein</strong> (isolated from retinoblastoma patients) is the product of an <strong>oncosuppressor gene. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is a <strong>cell cycle regulator</strong>, which <strong>binds and inactivates</strong> the <strong>E2F,</strong> a transcription factor <span style=\"font-family:Wingdings\">&rarr;</span>&nbsp;<strong>inhibition</strong> of cell cycle at <strong>G1</strong> phase. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In<strong> controlled </strong>cell cycles,<strong> cyclin D levels rise </strong>in the<strong> late G1 phase. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The<strong> cyclin D inactivates Rb</strong>, which is separated from E2F: normal mechanism to overcome the <strong>G1 arrest by Rb</strong> <span style=\"font-family:Wingdings\">&rarr;</span>&nbsp;Thus, <strong>Rb cannot inhibit cell cycle</strong> <span style=\"font-family:Wingdings\">&rarr;</span> continuous <strong>cell division and cancer.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/12/picture2.jpg\" style=\"height:333px; width:600px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A, B.&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>Genes</strong> causing cancer are <strong>oncogenes</strong>. e.g., myc, src, ras, abl, erb-B etc</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>Genes</strong> which <strong>protect </strong>the individual <strong>from cancer </strong>are <strong>Anti-oncogenes</strong> or&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Oncosuppressor</span></strong><span style=\"font-size:12.0pt\"> e.g., <strong>p53, pRB.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Retinoblastoma</strong> is most commonly associated with a <strong>mutation in the RB1 gene</strong>, which codes for the <strong>retinoblastoma protein (pRb).</strong> This <strong>protein</strong> is a <strong>tumor suppressor </strong>that regulates the <strong>cell cycle.</strong> <strong>Mutations</strong> in <strong>RB1 </strong>can lead to a <strong>loss</strong> of this <strong>regulatory function,</strong> allowing cells to <strong>proliferate uncontrollably </strong>and <strong>resulting in cancer.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">: DM Vasudevan 9/e: p 744.</span></strong></span></span></p>",
      "correct_choice_id": 68595,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9535,
      "choices": [
        {
          "id": 38107,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1/12</span></span></span></p>"
        },
        {
          "id": 38108,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3/4</span></span></span></p>"
        },
        {
          "id": 38109,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1/4</span></span></span></p>"
        },
        {
          "id": 38110,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1/2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 5-month-old girl of Ashkenazi Jewish descent, after a period of normal development, shows a plateau in developmental milestones. Initially exhibiting normal behaviors such as rolling over and smiling, she becomes less active and is unable to sit. Upon examination, her pediatrician in India notes hypotonia and an exaggerated startle reflex. An ophthalmologic examination reveals a cherry-red spot, leading to the suspicion of a lipid storage disease. Considering the family&#39;s background and the symptoms, what is the risk that the next child will also be affected by this condition?</span></span></span></p>",
      "unique_key": "Q4166078",
      "question_audio": null,
      "question_video": null,
      "map_id": 30215,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. 1/4</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>symptoms </strong>are suggestive of <strong>Tay-Sachs disease</strong>, an <strong>autosomal recessive disorder </strong>involving <strong>neurodegeneration </strong>and <strong>early death</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Metabolic diseases </strong>exhibit <strong>autosomal or X-linked recessive inheritance </strong>and in this <strong>female patient </strong>it is likely an <strong>autosomal disease</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>child&rsquo;s parents </strong>are <strong>obligate carriers </strong>and have <strong>one-fourth chance </strong>(25% recurrence risk) that their <strong>next child </strong>will be affected. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture4_4vZDc2y.jpg\" style=\"height:203px; width:350px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Developmental plateau</strong>, <strong>hypotonia</strong>, <strong>exaggerated startle reflex</strong>, and a <strong>cherry-red spot </strong>on <strong>ophthalmologic examination</strong>, is classic for <strong>Tay-Sachs disease</strong>, a <strong>type of lipid storage disease </strong>more commonly found among <strong>individuals of Ashkenazi Jewish descent</strong>. Tay-Sachs disease is an autosomal recessive disorder, which means that for a child to be affected, they must inherit two copies of the defective gene, one from each parent.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan&nbsp; 9/e: p 635, Lewis, pp 82-86. Scriver, pp 3827-3876. </span></span></strong></p>",
      "correct_choice_id": 38109,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9563,
      "choices": [
        {
          "id": 38219,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abnormal structure of cilia</span></span></span></p>"
        },
        {
          "id": 38220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abnormal levels of sphingomyelinase</span></span></span></p>"
        },
        {
          "id": 38221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">fibrillin deficiency</span></span></span></p>"
        },
        {
          "id": 38222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">47, XXY karyotype</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A couple has been seeking infertility treatment after 10 years of marriage. The wife&#39;s examination shows no significant findings. However, the husband has a history of bronchiectasis, situs inversus since childhood, and recurrent sinusitis. Further investigation reveals that he is sterile. What is the most likely cause of his infertility?</span></span></span></p>",
      "unique_key": "Q1654190",
      "question_audio": null,
      "question_video": null,
      "map_id": 30222,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Abnormal structure of cilia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Kartagener syndrome</span></strong><span style=\"font-size:12.0pt\">, an <strong>AR disorder </strong>characterized by <strong>bronchiectasis</strong>, <strong>sinusitis</strong>, and <strong>situs inversus</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is associated with the <strong>absence of inner </strong>or <strong>outer dynein arms in the cilia </strong></span><span style=\"font-size:12.0pt\">ðŸ¡ª</span><span style=\"font-size:12.0pt\"> leads to abnormal ciliary mobility of the sperm </span><span style=\"font-size:12.0pt\">ðŸ¡ª</span><span style=\"font-size:12.0pt\"> infertility. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ciliary abnormalities in the respiratory tract </span><span style=\"font-size:12.0pt\">ðŸ¡ª</span><span style=\"font-size:12.0pt\"> sinusitis and bronchiectasis. So it is classified as an <strong>&ldquo;immotile cilia syndrome&rdquo;.&nbsp; </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Abnormal levels of sphingomyelinase:</span></strong><span style=\"font-size:12.0pt\"> Sphingomyelinase deficiency results in <strong>Niemann-Pick disease </strong></span><span style=\"font-size:12.0pt\">ðŸ¡ª</span><span style=\"font-size:12.0pt\"> accumulation of Sphingomyelin in the phagocytes <strong>(Foam histocytes</strong>) &rarr; deposit in the liver, spleen, lymph nodes, and skin. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">C/F:</span></strong><span style=\"font-size:12.0pt\"> hepatosplenomegaly, neurologic deterioration and no survival beyond 3 years of age.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Fibrillin deficiency: </span></strong><span style=\"font-size:12.0pt\">Results<strong> </strong>in <strong>Marfan syndrome</strong>. <strong>C/F:</strong> Patients look tall and thin, arachnodactyly, ectopia lentis and aortic dilation leading to aortic aneurysm.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 47, XXY karyotype:</span></strong><span style=\"font-size:12.0pt\"> Seen in <strong>Klinefelter syndrome</strong>, <strong>characterized</strong> by male hypogonadism causing male infertility (as given in the case), atrophic testes, tall stature, gynecomastia, and mental retardation (Other features are not suggestive of the diagnosis).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Kartagener&#39;s syndrome</strong>, which is a <strong>subset of primary ciliary dyskinesia</strong>. This condition is characterized by a <strong>triad of situs inversus</strong>, <strong>chronic sinusitis</strong>, and <strong>bronchiectasis</strong>. It is caused by defects in the structure and function of ciliary motility, which affects not only respiratory cilia but also the cilia within the reproductive tract, leading to infertility due to impaired sperm motility.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 30/e:&nbsp; p 665.</span></strong></span></span></p>",
      "correct_choice_id": 38219,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9574,
      "choices": [
        {
          "id": 38263,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Unequal Crossing over</span></span></span></p>"
        },
        {
          "id": 38264,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Two-base insertion</span></span></span></p>"
        },
        {
          "id": 38265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Three-base deletion</span></span></span></p>"
        },
        {
          "id": 38266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Single-base substitution (point mutation) </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sickle cell anemia is characterized by a mutation in the &beta;-globin gene, resulting in the substitution of glutamic acid with valine at the sixth position of the &beta;-globin chain. What mechanism most likely underlies this specific genetic alteration?</span></span></span></p>",
      "unique_key": "Q6325313",
      "question_audio": null,
      "question_video": null,
      "map_id": 30225,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Single-base substitution (point mutation)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A <strong>change from one DNA codon </strong>to <strong>another </strong>cause&rsquo;s <strong>replacement of amino acids </strong>such as <strong>valine to glutamic acid</strong>, changes in the &beta;-globin peptide chain of haemoglobin S. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A <strong>single nucleotide substitution (point mutation)</strong> would <strong>affect </strong>such a <strong>codon change</strong> and involves a <strong>thymine to adenine substitution </strong>at the <strong>second position of the codon 6.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong><span style=\"font-size:12.0pt\"><strong>Equal exchange</strong> <strong>(crossing over)</strong> among <strong>homologous &beta;-globin genes</strong> could <strong>exchange alleles,</strong> by <strong>replacing normal alleles</strong> with <strong>mutant partners,</strong> or vice versa (converting heterozygosity to homozygosity). Unequal crossing over could generate mutant alleles with duplicated or deficient nucleotides but not substitution.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option (B, C):</span></strong><span style=\"font-size:12.0pt\"> <strong>One or two-base insertions</strong> changes the <strong>reading frame </strong>of the <strong>genetic code</strong> <strong>(frame-shift mutation)</strong> and usually <strong>produces a termination codon</strong> <strong>(chain-termination mutation)</strong> after the point of insertion. A three-base deletion will cause a deletion of an amino acid from protein and not substitution.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Sickle cell anemia</strong> is caused by a <strong>single-base substitution</strong> in the <strong>&beta;-globin gene,</strong> where <strong>adenine is replaced by thymine</strong>. This <strong>point mutation</strong> leads to the <strong>change from glutamic acid </strong>to <strong>valine </strong>at the <strong>sixth amino acid position </strong>in the <strong>&beta;-globin chain,</strong> which significantly alters the <strong>hemoglobin&#39;s properties</strong> and leads to the characteristic sickling of red blood cells under low oxygen conditions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 635</span></span></strong></p>",
      "correct_choice_id": 38266,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9590,
      "choices": [
        {
          "id": 38327,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biochemical testing</span></span></span></p>"
        },
        {
          "id": 38328,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluorescence in situ hybridization (FISH)&nbsp;&nbsp; </span></span></span></p>"
        },
        {
          "id": 38329,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polymerase chain reaction (PCR)&nbsp;&nbsp;&nbsp; </span></span></span></p>"
        },
        {
          "id": 38330,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotype analysis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old white woman and a 28-year-old white man are seeking genetic counselling in an Indian metropolitan hospital. They have a family history of cystic fibrosis affecting one of their siblings. Considering their concern about the risk of transmitting this autosomal recessive disorder to their future offspring, which genetic testing method would be most appropriate to assess their carrier status?</span></span></span></p>",
      "unique_key": "Q6135097",
      "question_audio": null,
      "question_video": null,
      "map_id": 30226,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Polymerase chain reaction (PCR)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp; <strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cystic fibrosis</strong> is an <strong>autosomal recessive disease </strong>due to <strong>point mutations </strong>or <strong>deletions in the gene encoding</strong> a <strong>chloride transporter</strong> (an integral membrane protein).&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>amplification of the mutated region</strong> using the <strong>PCR can be done</strong> &rarr; products are sequenced &rarr; compared with the normal sequence for this region. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If comparison shows deletion &rarr; the donor DNA would be the carrier.&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If no mutation &rarr; DNA donor as a carrier of cystic fibrosis is reduced, but still exists</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Biochemical testing:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> used to <strong>detect a defective enzyme </strong>or a <strong>decrease in levels of a normal enzyme</strong>. E.g. detects carriers of AR diseases such as Tay-Sachs disease, sickle cell anemia, and thalassemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Fluorescence in situ hybridization (FISH):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> used to <strong>detect micro deletions </strong>in a gene but can&rsquo;t detect a single base change.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Karyotype analysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> used to <strong>detect monosomies</strong>, <strong>trisomy</strong>, translocations, inversions, and deletions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Polymerase chain reaction </strong>(PCR) is the most <strong>appropriate method </strong>for <strong>detecting specific mutations </strong>in the <strong>CFTR gene </strong>associated with <strong>cystic fibrosis</strong>. PCR can amplify the regions of interest to determine if the couple carries the common mutations causing the disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: P 483.</span></strong></span></span></p>",
      "correct_choice_id": 38329,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9623,
      "choices": [
        {
          "id": 38459,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Northern blotting of red blood cell mRNA</span></span></span></p>"
        },
        {
          "id": 38460,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enzyme assay of red blood cell hemolysate</span></span></span></p>"
        },
        {
          "id": 38461,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Western blotting of red blood cell hemolysates</span></span></span></p>"
        },
        {
          "id": 38462,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amplification of red blood cell DNA and hybridization with allele-specific oligonucleotides (PCR-ASOs)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old boy, who had been receiving a sulphonamide antibiotic as a preventive measure for recurrent urinary tract infections, presents with worsening illness, pallor, and irritability. Laboratory findings reveal severe anemia and jaundice, indicative of hemolysis. Which test is the simplest for diagnosing his condition?</span></span></span></p>",
      "unique_key": "Q8874217",
      "question_audio": null,
      "question_video": null,
      "map_id": 30211,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Enzyme assay of red blood cell hemolysate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tropical African </strong>and <strong>Mediterranean peoples </strong>have <strong>highest prevalence </strong>because <strong>sickle cell trait </strong>confers <strong>resistance to malaria</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The phenotype of <strong>jaundice</strong> and <strong>RBC hemolysis with anemia</strong> is triggered by a variety of infections, drugs and dietary substances in fava beans. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sulphonamide&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and <strong>antimalarial drugs</strong> are noted for inducing hemolysis in G6PD- deficient individuals, which exhibits <strong>X- linked recessive inheritance</strong>, explains why male offspring but not the parents become ill when exposed to antimalarials. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Red cell hemolysis </strong>after <strong>drug exposure </strong>suggests a <strong>red cell enzyme defect</strong>, confirmed by <strong>enzyme assay</strong> to <strong>demonstrate deficient activity</strong>. A most likely diagnosis is glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common genetic disease. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Northern blotting </strong>of <strong>red blood cell mRNA </strong>is a <strong>complex procedure </strong>that is not typically used in a clinical setting for this purpose.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Western blotting </strong>of <strong>red blood cell hemolysates </strong>could theoretically <strong>detect the presence of G6PD protein</strong>, but it is not a quantitative assay and is more complex than an enzyme activity assay.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Amplification of red blood cell DNA </strong>and <strong>hybridization with allele-specific oligonucleotides </strong>(PCR-ASOs) is a <strong>genetic test </strong>that could identify mutations in the G6PD gene but is more complicated and not the first-line test for G6PD deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>G6PD deficiency </strong>due to <strong>sulphonamide antibiotic use</strong>, best diagnosed by a <strong>simple enzyme assay of red blood cell hemolysate</strong>. Other tests are more complex and less suited for this purpose.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Murray, pp 401-410. Scriver, pp 4517-4554. Lewis, pp 215-218. </span></strong></span></span></p>",
      "correct_choice_id": 38460,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9625,
      "choices": [
        {
          "id": 38467,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyploidy</span></span></span></p>"
        },
        {
          "id": 38468,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Balanced rearrangement</span></span></span></p>"
        },
        {
          "id": 38469,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ring formation</span></span></span></p>"
        },
        {
          "id": 38470,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unbalanced rearrangement</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-day-old female infant is examined with a cleft palate, congenital heart defect, postaxial polydactyly, a scalp defect, and distinctive facial features including hypertelorism. Karyotyping reveals a normal count of 46 chromosomes, but with additional genetic material on one of the chromosome 5 homologs. How is this chromosomal abnormality best categorized?</span></span></span></p>",
      "unique_key": "Q5904798",
      "question_audio": null,
      "question_video": null,
      "map_id": 30212,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D)</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Unbalanced rearrangement </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Extra material</strong> / <strong>extra chromatin </strong>seen on <strong>chromosome 5</strong> implies <strong>recombination of chromosome 5 DNA</strong> with that of another <strong>chromosome to produce a rearranged chromosome. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As this <strong>rearranged chromosome 5 </strong>takes the <strong>place of a normal chromosome 5,</strong> there is no change in number of the autosomes (non-sex chromosomes) or sex chromosomes (X and Y chromosomes) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&rsquo;s clinical findings are <strong>similar to trisomy 13</strong> or <strong>Patau syndrome</strong>, suggesting that the extra material on chromosome 5 is derived from the long arm of chromosome 13.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With this interpretation, the aberration would be more specifically described as duplication 13q (dup[13q]) or as partial trisomy for 13q.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. &amp; Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These <strong>chromosomal abnormalities</strong> involves changes in number (i.e., <strong>polyploidy and aneuploidy)</strong> or changes in structure (i.e., rearrangements such as <strong>translocations, rings, and inversions</strong>).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The scenario states that <strong>all cells examined from the patient</strong> (usually 11-25 cells) have the <strong>same chromosomal constitution</strong>, ruling out <strong>mosaicism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Extra material</strong> on <strong>chromosome 5 </strong>indicates an <strong>unbalanced chromosomal rearrangement,</strong> where there is <strong>extra genetic material</strong> present without a corresponding loss elsewhere. This can lead to a genetic surplus or deficiency, causing developmental and physical abnormalities such as those observed in the infant.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 31/<sup> </sup>e: p 877-879.</span></strong></span></span></p>",
      "correct_choice_id": 38470,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}